Regulations.gov document
Determination of Regulatory Review Period for Purposes of Patent Extension; ZILVER PTX…
Notice · FDA-2013-E-0681 · posted Jun 17, 2016
Key facts
| Document ID | FDA-2013-E-0681-0007 |
|---|---|
| Title | Determination of Regulatory Review Period for Purposes of Patent Extension; ZILVER PTX DRUG ELUTING PERIPHERAL STENT |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2013-E-0681 |
| Posted | Jun 17, 2016 |
| Federal Register citation | 81 FR 39648 |
| FR document number | 2016-14357 |
| Comment period opens | Jun 17, 2016 |
| Comments due | Dec 15, 2016 |
| Effective date | Jun 17, 2016 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: